Clinical Trial Update: Study of Injectable Naltrexone and Oral Bupropion Among Cigarette Smokers With Schizophrenia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating injectable naltrexone in combination with oral bupropion for smoking cessation in adults with schizophrenia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Schizophrenia

Drugs mentioned

• Naltrexone (Naltrexone)
• bupropion (bupropion)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Smoking Cessation | Phase 1 | Status: TERMINATED